News
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Noom will start offering smaller doses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...
The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Volusia County Schools has abandoned its local health-insurance provider for a Texas startup led by a 30-year-old British ex-pat.
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.
Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Longevity startups have become trendy in digital health, drawing attention from celebrity and established investors.
Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.
BURLINGAME, CA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Global health coach market is estimated to be valued at USD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results